4th European Biosimilars Conference

As the 4th conference of its kind, the 2016 programme gives a complete 360-degree overview of biosimilar medicines. Participants will leave the conference with a wealth of new information and an expanded network of contacts.

Back to Agenda

Key Note

Speaker(s)

Market Developments in Europe and Globally

Per Troein, MBA, MSc

IQVIA, United Kingdom

VP Strategic Partners

Have an account?

4th European Biosimilars Conference

Key Note

Speaker(s)

Market Developments in Europe and Globally

Be informed and stay engaged.